ATE419005T1 - Staphylococcus aureus exopolysaccharid und verfahren - Google Patents

Staphylococcus aureus exopolysaccharid und verfahren

Info

Publication number
ATE419005T1
ATE419005T1 AT02790044T AT02790044T ATE419005T1 AT E419005 T1 ATE419005 T1 AT E419005T1 AT 02790044 T AT02790044 T AT 02790044T AT 02790044 T AT02790044 T AT 02790044T AT E419005 T1 ATE419005 T1 AT E419005T1
Authority
AT
Austria
Prior art keywords
staphylococcus aureus
sae
antigen
aureus exopolysaccharide
immunogenic
Prior art date
Application number
AT02790044T
Other languages
English (en)
Inventor
Joseph JOYCE
James Cook
Chitrananda Abeygunawardana
Karen Grimm
Craig Przysiecki
Robert Hepler
Charlotte Ip
Keith Roper
Qinwei Xu
Kathrin Jansen
Paul Keller
Leslie Cope
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE419005T1 publication Critical patent/ATE419005T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT02790044T 2001-12-11 2002-12-06 Staphylococcus aureus exopolysaccharid und verfahren ATE419005T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34675501P 2001-12-11 2001-12-11
US35594102P 2002-02-11 2002-02-11

Publications (1)

Publication Number Publication Date
ATE419005T1 true ATE419005T1 (de) 2009-01-15

Family

ID=26995003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02790044T ATE419005T1 (de) 2001-12-11 2002-12-06 Staphylococcus aureus exopolysaccharid und verfahren

Country Status (7)

Country Link
US (1) US7157443B2 (de)
EP (1) EP1455817B1 (de)
JP (1) JP2005532415A (de)
AT (1) ATE419005T1 (de)
CA (1) CA2469132A1 (de)
DE (1) DE60230670D1 (de)
WO (1) WO2003053462A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU2003290867A1 (en) * 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2004043405A2 (en) * 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
NZ544542A (en) * 2003-07-24 2009-01-31 Merck & Co Inc Polypeptides for inducing a protective immune response against staphylococcus aureus
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
ES2730275T3 (es) 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
US7811572B2 (en) 2005-08-24 2010-10-12 Immunogen, Inc. Process for preparing purified drug conjugates
AU2006213662B2 (en) * 2005-02-11 2010-08-05 Immunogen, Inc. Process for preparing stable drug conjugates
AR060187A1 (es) * 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Composicion inmunogenica
NZ570805A (en) 2006-03-30 2011-10-28 Glaxosmithkline Biolog Sa Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2697373C (en) 2007-08-27 2019-05-21 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
AU2008343745B2 (en) 2007-10-01 2012-05-10 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
WO2009155059A2 (en) * 2008-05-28 2009-12-23 Trustees Of Tufts College Polysaccharide composition and methods of isolation of the emulsion stabilizing cationic polyelectrolytic polysaccharide
CN102159540B (zh) * 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
US20110262477A1 (en) 2008-10-06 2011-10-27 University Of Chicago Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
HRP20160274T1 (hr) 2009-04-03 2016-04-08 University Of Chicago Pripravci i metode vezane za varijante proteina a (spa)
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
JP5784592B2 (ja) 2009-06-03 2015-09-24 イミュノジェン・インコーポレーテッド 抱合方法
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
CN102687014B (zh) * 2009-11-30 2017-10-03 积水医疗株式会社 均相测量方法和测量试剂
EP2555794A4 (de) 2010-04-05 2014-01-15 Univ Chicago Zusammensetzungen und verfahren im zusammenhang mit protein-a-(spa)-antikörpern als immunreaktionsverstärker
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
EA033468B1 (ru) 2011-03-29 2019-10-31 Immunogen Inc Способы получения конъюгата "антитело-майтансиноид"
WO2012150603A1 (en) * 2011-05-04 2012-11-08 Serum Institute Of India Ltd. Removal of "polyose type" teichoic acid contaminants from bacterial polyoses
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CA3207612A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2013162746A1 (en) 2012-04-26 2013-10-31 University Of Chicago Staphylococcal coagulase antigens and methods of their use
EP2904089A4 (de) 2012-10-04 2016-05-25 Immunogen Inc Verwendung einer pvdf-membran zur reinigung von konjugaten aus zellbindendem mittel und zytotoxikum
EP3294448A4 (de) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Schnellverfahren zur extraktion von nukleinsäuren aus biologischen proben
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
CA3139981A1 (en) 2019-05-14 2020-11-19 The University Of Chicago Methods and compositions comprising staphylococcus protein a (spa) variants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
ES2051621B1 (es) 1992-02-04 1995-01-16 Consejo Superior Investigacion Procedimiento de obtencion de vacuna frente a estafilococos.
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US7252828B2 (en) * 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
DE69938784D1 (de) 1998-07-15 2008-07-03 Brigham & Womens Hospital Polysaccharid-impfstoff gegen staphylokokken infektionen

Also Published As

Publication number Publication date
DE60230670D1 (de) 2009-02-12
US20040259838A1 (en) 2004-12-23
EP1455817B1 (de) 2008-12-31
WO2003053462A3 (en) 2003-09-04
JP2005532415A (ja) 2005-10-27
EP1455817A4 (de) 2005-11-30
CA2469132A1 (en) 2003-07-03
US7157443B2 (en) 2007-01-02
WO2003053462A2 (en) 2003-07-03
EP1455817A2 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
DE60230670D1 (de) Staphylococcus aureus exopolysaccharid und verfahren
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
CY1105500T1 (el) Αντιγονο και εμβολιο απο staphylococcus
DE122010000042I1 (de) Solubilisierung von capsulären Polysacchariden
ATE426412T1 (de) Adjuvante influenza-vakzine
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
DE60138115D1 (de) Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2004043405A3 (en) Polysaccharide vaccine for staphylococcal infections
DK0549617T3 (da) Forbedrede vaccinepræparater
PL374523A1 (pl) Koniugaty pochodna kalicheamycyny-nośnik
AR030245A1 (es) Composiciones de gel que contienen metronidazol
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
BR0210139A (pt) Composições farmacêuticas
MXPA05009351A (es) Conjugados de polisacarido-proteina portadora adhesina superficial de estafilococo para inmunizacion contra infecciones nosocomiales.
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
DE50104047D1 (de) Therapie- und trainingsgerät für das schultergelenk
DK1268844T3 (da) Modulering af fremstilling af pneumococcus kapselformigt polysaccharid
ATE395931T1 (de) Polysaccharid-impfstoff gegen staphylokokken infektionen
EA200400211A1 (ru) Лиофилизованная композиция 2-метилтиенобензодиазепина
ITVA20020023A1 (it) Prodotti per l'edilizia a base di idrossialchilguaro purificato
DK1037642T3 (da) Modificerede polysaccharider med ændret biologisk genkendelse
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
DE69206075D1 (de) Impfstoff gegen nematoden.
ATE393160T1 (de) Derivative von 9,10-dihydro-9-oxa-10- phosphaphenanthren-10-oxid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties